Where the revenue comes from
Quarter 2026/Q2
By business line
Health$512.20M 39.4%
Life$272.50M 21.0%
Annuity$174.10M 13.4%
Change in market values of the underlying options supporting the fixed indexed annuity and life$161.80M 12.4%
Investment income not allocated to product lines$152.90M 11.8%
Fee revenue$18.50M 1.4%
Revenues related to earnings attributable to Variable interest entities (VIEs)$3.80M 0.3%
Fee revenue related to divested business$3.30M 0.3%
Amounts netted in expenses not allocated to product lines$800,000.00 0.1%
No financial statements on file for this stock.
No comments yet — be the first to weigh in on CNO.